Softwr

Healthcare · head to head

Doximity vs Paige

Doximity logo

Doximity

Healthcare

Social network and collaboration platform for physicians

From
Free
Rated
-
Full reviewWebsite
Paige logo

Paige

Healthcare

Digital pathology AI holding the first FDA De Novo authorisation for a pathology algorithm, now part of Tempus

From
On request
Rated
-
Full reviewWebsite

The short version

  • Only Doximity has a free tier, so it costs nothing to try first.
  • Each has a real cost: Doximity free tier limited to verified US clinicians only; no international access without premium; Paige the FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • They diverge on capability: Doximity covers Secure Messaging, Paige covers Paige Prostate Detect.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Doximity and Paige actually diverge.

Attributes where Doximity and Paige differ
AttributeDoximityPaige
Starting priceFreeOn request
Pricing modelfreemiumquote
Free tierYesNo
PlatformsWeb, iOS, AndroidWeb, Cloud, On-premise
Founded2010Unknown

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Doximity

  • Secure Messaging
  • Professional Network
  • Telehealth
  • Job Board
  • CME Access
  • Collaboration Tools
  • EHR Systems
  • HIPAA

Only in Paige

  • Paige Prostate Detect
  • Paige Prostate Grade and Quantify
  • Perineural invasion detection
  • Breast and lymph node applications
  • FullFocus viewer
  • Foundation models
  • OmniScreen
  • Paige Alba

What people use each for

The jobs each tool is most often brought in to do.

Doximity

  • Physician professional network and communicationnot Paige
  • AI-powered medical reference and clinical decision supportnot Paige
  • Patient outreach and documentation automationnot Paige

Paige

  • A reference laboratory processing high volumes of prostate core needle biopsies where a second read on every case is not staffablenot Doximity
  • A pathology department already digitised that wants a documented safety net against missed small foci of cancernot Doximity
  • A hospital laboratory struggling to recruit uropathology subspecialists and needing consistency across generalist reportingnot Doximity
  • A pharmaceutical company needing consistent biomarker scoring across trial sites rather than site-by-site pathologist variabilitynot Doximity

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Doximity

  • Free tier limited to verified US clinicians only; no international access without premium
  • AI Scribe and Dialer features accessible only to US-based healthcare professionals
  • Premium tier pricing not disclosed on main site

Paige

  • The FDA authorisation is confined to prostate core needle biopsies, on compatible scanners, viewed through FullFocus, as an adjunct only; every other tissue type and every grading claim is outside that authorisation in the United States.
  • The algorithm is worthless without a digital pathology programme already running, and slide scanning, storage and workflow typically cost far more than the software licence.
  • Tempus acquired Paige in 2025, so the roadmap now competes for attention inside a genomics-led business, and the pathology-only buyer is no longer the primary customer.
  • Scanner compatibility is a hard constraint rather than a preference, and a laboratory with an unsupported scanner fleet cannot use the authorised indication at all.
  • Pricing is per case or per slide and unpublished, so a laboratory cannot model cost per reported case without entering a sales process.

Pricing, plan by plan

Doximity

Free

No published plan breakdown. See the Doximity review.

Paige

On request
  • Paige clinical applications$undefined/year
    • Priced per case or per slide analysed under annual agreement
    • Prostate, breast and other applications licensed separately
    • Requires compatible whole slide scanner and the FullFocus viewer for the authorised indication

Which should you pick?

Choose Doximity if

  • You need secure messaging.
  • You want to start without paying.
  • You work on Web, iOS, Android.
  • You also want professional network.
Doximity review

Choose Paige if

  • You need paige prostate detect.
  • You work on Web, Cloud, On-premise.
  • You also want paige prostate grade and quantify.
Paige review

Questions people ask

Is Doximity or Paige better?
Neither clearly leads. Doximity starts at Free and Paige at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Doximity or Paige?
Doximity has a free tier; the other does not. Paid plans start at Free for Doximity and On request for Paige.
Does Doximity or Paige run on more platforms?
Doximity runs on Web, iOS, Android. Paige runs on Web, Cloud, On-premise.
Can I use Doximity for free?
Yes. Doximity has a free tier, so you can try it without paying. Paige starts at On request.
What is Doximity best used for?
Doximity is most often used for physician professional network and communication, ai-powered medical reference and clinical decision support, patient outreach and documentation automation. Of those, physician professional network and communication and ai-powered medical reference and clinical decision support are not what Paige is typically brought in for.
What can Doximity do that Paige cannot?
Doximity covers Secure Messaging, Professional Network, Telehealth, Job Board. Paige covers Paige Prostate Detect, Paige Prostate Grade and Quantify, Perineural invasion detection, Breast and lymph node applications.

Answered from the vendors’ own pages

Doximity: Is Doximity free?

Doximity is free for verified US clinicians. Specific subscription tiers and paid plan pricing are not disclosed on their website.

Source
Paige: What exactly is FDA authorised?

Paige Prostate Detect, as an adjunct for identifying areas of interest on digitised prostate core needle biopsy slides, viewed through the Paige FullFocus viewer on a compatible scanner. Nothing else in the portfolio holds that authorisation in the United States.

Paige: Is the European position broader?

Yes. The Paige Prostate suite including grading and quantification received IVDR certification in 2025, which covers more than the United States authorisation.

Paige: What did the pivotal study measure?

Pathologist cancer detection on individual slide images improved, with reported reductions in false negative and false positive readings. It measured pathologist performance with the tool, not standalone algorithm accuracy.

Paige: Who owns Paige now?

Tempus AI acquired Paige in 2025. Products remain branded Paige.

Share

Related pages

More on Doximity

More on Paige

Keep looking

Other head to heads